Only missense mutations affecting the DNA binding domain of p53 influence outcomes in patients with breast carcinoma.
about
PCR-Based Simple Subgrouping Is Validated for Classification of Gliomas and Defines Negative Prognostic Copy Number Aberrations in IDH Mutant Gliomas.TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays.Pharmacological Measures of Treatment Adherence and Risk of HIV Infection in the VOICE Study.Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast Cancer.Missense mutations in the TP53 DNA-binding domain predict outcomes in patients with advanced oral cavity squamous cell carcinoma.Unequal prognostic potentials of p53 gain-of-function mutations in human cancers associate with drug-metabolizing activityPatterns and Biologic Features of p53 Mutation Types in Korean Breast Cancer Patients.Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study.The effect of immunohistochemically detected p53 accumulation in prognosis of breast cancer; A retrospective survey of outcome.TP53 gene expression levels and tumor aggressiveness in canine mammary carcinomas.Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma.Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing.Prolonged remission of advanced bronchoalveolar adenocarcinoma in a dog treated with autologous, tumour-derived chaperone-rich cell lysate (CRCL) vaccine.Prognostic significance of CD117 expression and TP53 missense mutations in triple-negative breast cancer.
P2860
Q35838374-B7A95FB4-2251-48E9-8DF8-B211D34F217FQ36376097-7E1530D0-FDAA-4731-96A5-C03DA89D9491Q36440225-4701F4A9-132E-4B91-8F7E-8B56076BEB34Q37367403-2193B2E6-971F-466B-B675-2BC743AC083BQ37536831-5CC0D248-EA73-4E70-BC82-4F4D8C547CFFQ37680206-5604CA1C-BB84-4123-A4A1-B8C09868B599Q38778616-EAF94749-5006-4DA7-988E-77C3CA8F6237Q39217123-3FE823E6-B905-465D-8E21-EB4888C7B743Q41236981-AAE083D1-40B0-48E0-804E-567558B95965Q48016182-FF47C9A7-F07E-4755-8933-8AF9D57CD09AQ49884832-1361EFD5-531E-47F2-9CD9-4CF61BC1EFF1Q49901846-69AE0CCF-D034-48D3-9B4B-7339FCF2E855Q50891745-82D128B5-0389-427E-A759-4EF1C6D6664CQ55008104-59EA883F-251C-44B6-8921-4DC92055B440
P2860
Only missense mutations affecting the DNA binding domain of p53 influence outcomes in patients with breast carcinoma.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Only missense mutations affect ...... atients with breast carcinoma.
@ast
Only missense mutations affect ...... atients with breast carcinoma.
@en
Only missense mutations affect ...... atients with breast carcinoma.
@nl
type
label
Only missense mutations affect ...... atients with breast carcinoma.
@ast
Only missense mutations affect ...... atients with breast carcinoma.
@en
Only missense mutations affect ...... atients with breast carcinoma.
@nl
prefLabel
Only missense mutations affect ...... atients with breast carcinoma.
@ast
Only missense mutations affect ...... atients with breast carcinoma.
@en
Only missense mutations affect ...... atients with breast carcinoma.
@nl
P2093
P2860
P1433
P1476
Only missense mutations affect ...... atients with breast carcinoma.
@en
P2093
Magali Rebucci
Muriel Cadouot
Romain Boidot
Sandy Chevrier
Sarab Lizard-Nacol
P2860
P304
P356
10.1371/JOURNAL.PONE.0055103
P407
P577
2013-01-24T00:00:00Z